open access

Vol 22, No 1 (2017)
Original research articles
Published online: 2017-01-01
Submitted: 2016-02-05
Get Citation

Why do we need irradiation of internal mammary lymph nodes in patients with breast cancer: Analysis of lymph flow and radiotherapy studies

Novikov Sergey Nikolaevich, Kanaev Sergey Vasilevich
DOI: 10.1016/j.rpor.2016.09.012
·
Rep Pract Oncol Radiother 2017;22(1):37-41.

open access

Vol 22, No 1 (2017)
Original research articles
Published online: 2017-01-01
Submitted: 2016-02-05

Abstract

Aim

Using clinical data and results of lymphoscintigraphy to calculate probability of internal mammary lymph node (IMLN) invasion by breast cancer (BC). To evaluate clinical value of lymphoscintigraphy as the guide for irradiation of IMLN.

Methods

Using the data of eight published studies that analyzed lymph flow from primary BC (4541pts) after intra-peri-tumoral injection of nanosized 99mTc-colloids we determined probability of lymph-flow from internal-central and external BC to IMLN. In 7 studies (4359pts) axillary staging was accompanied by IMLN biopsy (911pts) that helped us to estimate probability of IMLN metastatic invasion in relation to the status of axillary LN. Finally, we estimated probability of IMLN invasion by BC in five randomized and observation studies that analyzed effect of IMLN irradiation on overall survival (OS). We calculated possible gain in survival if they would be treated according to lymph-flow guided radiotherapy to IMLN.

Results

Lymph-flow from internal/central BC to IMLN was mentioned in 35% from external lesions – in 16% cases. In women with negative axillary LN metastases in IMLN were revealed in 7.8%pts, in the case of positive axillary nodes average risk of IMLN invasion increased to 38.1%. Calculated probability of IMLN metastatic invasion in pts included in evaluated trials did not exceed 10%. If lymphoscintigraphy would drive decision about irradiation of IMLN than 72–78% of pts included in these studies would escape radiotherapy to IMLN. In the remaining 21–28%pts with lymph-flow to IMLN their irradiation probably would increase gain in OS from 1.0–3.3% to 4.3–16.8%.

Conclusion

Lymphoscintigraphy can be used to optimize the strategy of IMLN irradiation.

Abstract

Aim

Using clinical data and results of lymphoscintigraphy to calculate probability of internal mammary lymph node (IMLN) invasion by breast cancer (BC). To evaluate clinical value of lymphoscintigraphy as the guide for irradiation of IMLN.

Methods

Using the data of eight published studies that analyzed lymph flow from primary BC (4541pts) after intra-peri-tumoral injection of nanosized 99mTc-colloids we determined probability of lymph-flow from internal-central and external BC to IMLN. In 7 studies (4359pts) axillary staging was accompanied by IMLN biopsy (911pts) that helped us to estimate probability of IMLN metastatic invasion in relation to the status of axillary LN. Finally, we estimated probability of IMLN invasion by BC in five randomized and observation studies that analyzed effect of IMLN irradiation on overall survival (OS). We calculated possible gain in survival if they would be treated according to lymph-flow guided radiotherapy to IMLN.

Results

Lymph-flow from internal/central BC to IMLN was mentioned in 35% from external lesions – in 16% cases. In women with negative axillary LN metastases in IMLN were revealed in 7.8%pts, in the case of positive axillary nodes average risk of IMLN invasion increased to 38.1%. Calculated probability of IMLN metastatic invasion in pts included in evaluated trials did not exceed 10%. If lymphoscintigraphy would drive decision about irradiation of IMLN than 72–78% of pts included in these studies would escape radiotherapy to IMLN. In the remaining 21–28%pts with lymph-flow to IMLN their irradiation probably would increase gain in OS from 1.0–3.3% to 4.3–16.8%.

Conclusion

Lymphoscintigraphy can be used to optimize the strategy of IMLN irradiation.

Get Citation

Keywords

BC; Internal mammary; Radiotherapy; Sentinel lymph-nodes

About this article
Title

Why do we need irradiation of internal mammary lymph nodes in patients with breast cancer: Analysis of lymph flow and radiotherapy studies

Journal

Reports of Practical Oncology and Radiotherapy

Issue

Vol 22, No 1 (2017)

Pages

37-41

Published online

2017-01-01

DOI

10.1016/j.rpor.2016.09.012

Bibliographic record

Rep Pract Oncol Radiother 2017;22(1):37-41.

Keywords

BC
Internal mammary
Radiotherapy
Sentinel lymph-nodes

Authors

Novikov Sergey Nikolaevich
Kanaev Sergey Vasilevich

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk, Poland
tel.:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: journals@viamedica.pl